Atlas Trials

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Clinical trial NCT00644059 · COMPLETED

Trial details

NCT number
NCT00644059
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza, Human
Start date
2007-11-01
Primary completion
2010-04-01
Enrollment
4902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.